BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fuchs H, Hölscher AH, Leers J, Bludau M, Brinkmann S, Schröder W, Alakus H, Mönig S, Gutschow CA. Long-term quality of life after surgery for adenocarcinoma of the esophagogastric junction: extended gastrectomy or transthoracic esophagectomy? Gastric Cancer 2016;19:312-7. [PMID: 25627475 DOI: 10.1007/s10120-015-0466-3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Blank S, Schmidt T, Heger P, Strowitzki MJ, Sisic L, Heger U, Nienhueser H, Haag GM, Bruckner T, Mihaljevic AL, Ott K, Büchler MW, Ulrich A. Surgical strategies in true adenocarcinoma of the esophagogastric junction (AEG II): thoracoabdominal or abdominal approach? Gastric Cancer 2018;21:303-14. [DOI: 10.1007/s10120-017-0746-1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
2 Tseng J, Posner MC. For Gastroesophageal Junction Cancers, Does an "Esophageal" or "Gastric" Surgical Approach Offer Better Perioperative and Oncologic Outcomes? Ann Surg Oncol 2020;27:511-7. [PMID: 31571057 DOI: 10.1245/s10434-019-07732-x] [Reference Citation Analysis]
3 Schröder W, Lambertz R, van Hillegesberger R, Bruns C. [Differentiated surgical approach for adenocarcinoma of the gastroesophageal junction]. Chirurg 2017;88:1010-6. [PMID: 29098306 DOI: 10.1007/s00104-017-0544-7] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
4 Leers JM, Knepper L, van der Veen A, Schröder W, Fuchs H, Schiller P, Hellmich M, Zettelmeyer U, Brosens LAA, Quaas A, Ruurda JP, van Hillegersberg R, Bruns CJ. The CARDIA-trial protocol: a multinational, prospective, randomized, clinical trial comparing transthoracic esophagectomy with transhiatal extended gastrectomy in adenocarcinoma of the gastroesophageal junction (GEJ) type II. BMC Cancer 2020;20:781. [PMID: 32819399 DOI: 10.1186/s12885-020-07152-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Hoeppner J, Plum PS, Buhr H, Gockel I, Lorenz D, Ghadimi M, Bruns C; Qualitätskommission der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie. [Surgical treatment of esophageal cancer-Indicators for quality in diagnostics and treatment]. Chirurg 2021;92:350-60. [PMID: 32876700 DOI: 10.1007/s00104-020-01267-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Dhayat SA, Schacht R, Mennigen R, Palmes D, Vogel T, Vowinkel T, Senninger N, Laukoetter MG. Long-Term Quality of Life Assessment After Successful Endoscopic Vacuum Therapy of Defects in the Upper Gastrointestinal Tract Quality of Life After EVT. J Gastrointest Surg. 2019;23:280-287. [PMID: 30430432 DOI: 10.1007/s11605-018-4038-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
7 Kauppila JH, Ringborg C, Johar A, Lagergren J, Lagergren P. Health-related quality of life after gastrectomy, esophagectomy, and combined esophagogastrectomy for gastroesophageal junction adenocarcinoma. Gastric Cancer. 2018;21:533-541. [PMID: 28852939 DOI: 10.1007/s10120-017-0761-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
8 Heger P, Blank S, Gooßen K, Nienhüser H, Diener MK, Ulrich A, Mihaljevic AL, Schmidt T. Thoracoabdominal versus transhiatal surgical approaches for adenocarcinoma of the esophagogastric junction-a systematic review and meta-analysis. Langenbecks Arch Surg 2019;404:103-13. [PMID: 30607534 DOI: 10.1007/s00423-018-1745-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
9 Li KK, Bao T, Wang YJ, Liu XH, Guo W. The Postoperative outcomes of thoracoscopic-laparoscopic Ivor-Lewis surgery plus D2 celiac lymphadenectomy for patients with adenocarcinoma of the esophagogastric junction. Surg Endosc 2020;34:4957-66. [PMID: 31823049 DOI: 10.1007/s00464-019-07288-7] [Reference Citation Analysis]
10 Irino T, Tsekrekos A, Coppola A, Scandavini CM, Shetye A, Lundell L, Rouvelas I. Long-term functional outcomes after replacement of the esophagus with gastric, colonic, or jejunal conduits: a systematic literature review. Dis Esophagus. 2017;30:1-11. [PMID: 28881882 DOI: 10.1093/dote/dox083] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
11 Kamarajah SK, Phillips AW, Griffiths EA, Ferri L, Hofstetter WL, Markar SR. Esophagectomy or Total Gastrectomy for Siewert 2 Gastroesophageal Junction (GEJ) Adenocarcinoma? A Registry-Based Analysis. Ann Surg Oncol 2021. [PMID: 34255246 DOI: 10.1245/s10434-021-10346-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Lee HJ, Ock M, Kim KP, Jo MW. Estimation of population-based utility weights for gastric cancer-related health states. Patient Prefer Adherence 2018;12:909-18. [PMID: 29872276 DOI: 10.2147/PPA.S151946] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 2.8] [Reference Citation Analysis]
13 Bulamu NB, Chen G, Ratcliffe J, Schloite A, Bright T, Watson DI. Health-Related Quality of Life Associated with Barrett's Esophagus and Cancer. World J Surg 2019;43:1554-62. [PMID: 30719557 DOI: 10.1007/s00268-019-04936-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
14 Jung MK, Schmidt T, Chon SH, Chevallay M, Berlth F, Akiyama J, Gutschow CA, Mönig SP. Current surgical treatment standards for esophageal and esophagogastric junction cancer.Ann N Y Acad Sci. 2020;1482:77-84. [PMID: 32798235 DOI: 10.1111/nyas.14454] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Asadi-Lari M, Homaee-Shandiz F, Esmaeili-Hesari A. Changes in health-related quality of life in oesophagogastric cancer patients participating in palliative and curative therapies. Med J Islam Repub Iran 2018;32:31. [PMID: 30159282 DOI: 10.14196/mjiri.32.31] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Nobel T, Molena D. Surgical principles for optimal treatment of esophagogastric junction adenocarcinoma. Ann Gastroenterol Surg 2019;3:390-5. [PMID: 31346578 DOI: 10.1002/ags3.12268] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
17 Jezerskyte E, Saadeh LM, Hagens ERC, Sprangers MAG, Noteboom L, van Laarhoven HWM, Eshuis WJ, van Berge Henegouwen MI, Gisbertz SS. Long-Term Quality of Life After Total Gastrectomy Versus Ivor Lewis Esophagectomy. World J Surg 2020;44:838-48. [PMID: 31732762 DOI: 10.1007/s00268-019-05281-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
18 Heits N, Bernsmeier A, Reichert B, Hauser C, Hendricks A, Seifert D, Richter F, Schafmayer C, Ellrichmann M, Schniewind B, Hampe J, Becker T, Egberts JH. Long-term quality of life after endovac-therapy in anastomotic leakages after esophagectomy. J Thorac Dis 2018;10:228-40. [PMID: 29600053 DOI: 10.21037/jtd.2017.12.31] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
19 Hoefnagel SJM, Boonstra JJ, Russchen MJAM, Krishnadath KK. Towards Personalized Treatment Strategies for Esophageal Adenocarcinoma; A Review on the Molecular Characterization of Esophageal Adenocarcinoma and Current Research Efforts on Individualized Curative Treatment Regimens. Cancers (Basel) 2021;13:4881. [PMID: 34638363 DOI: 10.3390/cancers13194881] [Reference Citation Analysis]
20 Brinkmann S, Knepper L, Fuchs H, Hoelscher A, Kuhr K, Dos Santos DP, Plum P, Chon SH, Bruns C, Schroeder W, Leers J. Short- and long-term follow-up of patients with non-neoplastic esophageal perforation. Langenbecks Arch Surg 2021. [PMID: 34562118 DOI: 10.1007/s00423-021-02327-1] [Reference Citation Analysis]
21 Fuchs HF, Broderick RC, Harnsberger CR, Divo FA, Coker AM, Jacobsen GR, Sandler BJ, Bouvet M, Horgan S. Intraoperative Endoscopic Botox Injection During Total Esophagectomy Prevents the Need for Pyloromyotomy or Dilatation. J Laparoendosc Adv Surg Tech A 2016;26:433-8. [PMID: 27043862 DOI: 10.1089/lap.2015.0575] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
22 Zhao B, Zhang Z, Mo D, Lu Y, Hu Y, Yu J, Liu H, Li G. Optimal Extent of Transhiatal Gastrectomy and Lymphadenectomy for the Stomach-Predominant Adenocarcinoma of Esophagogastric Junction: Retrospective Single-Institution Study in China. Front Oncol 2018;8:639. [PMID: 30719422 DOI: 10.3389/fonc.2018.00639] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Oh SE, Lee GH, An JY, Lee JH, Sohn TS, Bae JM, Kim S, Choi MG. Comparison of transabdominal and transthoracic surgical approaches in the treatment of Siewert type II esophagogastric junction cancers: A propensity score-matching analysis. Eur J Surg Oncol 2021:S0748-7983(21)00675-2. [PMID: 34433514 DOI: 10.1016/j.ejso.2021.08.006] [Reference Citation Analysis]
24 Munitiz V, Ortiz A, Ruiz de Angulo D, F Martinez de Haro L, Parrilla P. Results of the different surgical options for the treatment of cancer of the esophagogastric junction: Review of the evidence. Cir Esp (Engl Ed) 2019;97:445-50. [PMID: 31027834 DOI: 10.1016/j.ciresp.2019.03.005] [Reference Citation Analysis]
25 De Pasqual CA, van der Sluis PC, Weindelmayer J, Lagarde SM, Giacopuzzi S, De Manzoni G, Wijnhoven BPL. Transthoracic esophagectomy compared to transhiatal extended gastrectomy for adenocarcinoma of the esophagogastric junction: a multicenter retrospective cohort study. Dis Esophagus 2021:doab090. [PMID: 34969080 DOI: 10.1093/dote/doab090] [Reference Citation Analysis]
26 Brown AM, Giugliano DN, Berger AC, Pucci MJ, Palazzo F. Surgical approaches to adenocarcinoma of the gastroesophageal junction: the Siewert II conundrum. Langenbecks Arch Surg. 2017;402:1153-1158. [PMID: 28803334 DOI: 10.1007/s00423-017-1610-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
27 Wu H, Shang L, Du F, Fu M, Liu J, Fang Z, Li L. Transhiatal versus transthoracic surgical approach for Siewert type Ⅱ adenocarcinoma of the esophagogastric junction: a meta-analysis. Expert Rev Gastroenterol Hepatol 2020;14:1107-17. [PMID: 32757864 DOI: 10.1080/17474124.2020.1806710] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Song Q, Li X, Wu D, Li S, Xie T, Lu Y, Zhang L, Xu Z, Liu L, Guo X, Wang X. The abdominal-transhiatal surgical approach versus the thoracoabdominal surgical approach in Siewert type II adenocarcinoma of the esophagogastric junction: protocol for a multicenter prospective, open, parallel, and randomized controlled trial. BMC Cancer 2022;22:318. [PMID: 35331180 DOI: 10.1186/s12885-022-09375-w] [Reference Citation Analysis]
29 Wu Y, Zhang S, Wang L, Hu X, Zhang Z. Comparative analysis of laparoscopic proximal gastrectomy plus semi-embedded valve anastomosis with laparoscopic total gastrectomy for adenocarcinoma of the esophagogastric junction: a single-center retrospective cohort study. World J Surg Oncol 2021;19:50. [PMID: 33588854 DOI: 10.1186/s12957-021-02163-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Coevoet D, Van Daele E, Willaert W, Huvenne W, Van de Putte D, Ceelen W, Deron P, Pattyn P, Van Nieuwenhove Y. Quality of life of patients with a colonic interposition postoesophagectomy. Eur J Cardiothorac Surg 2019;55:1113-20. [PMID: 30544187 DOI: 10.1093/ejcts/ezy398] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
31 Fuchs HF, Schmidt HM, Meissner M, Brinkmann S, Maus M, Bludau M, Schröder W, Hölscher AH, Leers JM. Endoscopic and histopathologic reflux-associated mucosal damage in the remnant esophagus following transthoracic esophagectomy for cancer-5-year long-term follow-up. Dis Esophagus 2018;31:1-6. [PMID: 29036607 DOI: 10.1093/dote/dox115] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
32 Schmitz SM, Alizai PH, Eickhoff RM, Schooren L, Kroh A, Roeth AA, Neumann UP, Klink CD. Minimally Invasive Thoracoabdominal Esophagectomy Is Superior to Minimally Invasive Gastrectomy in Terms of Health-Related Quality of Life. J Laparoendosc Adv Surg Tech A 2021;31:306-13. [PMID: 32960143 DOI: 10.1089/lap.2020.0509] [Reference Citation Analysis]
33 Ukegjini K, Vetter D, Fehr R, Dirr V, Gubler C, Gutschow CA. Functional syndromes and symptom-orientated aftercare after esophagectomy. Langenbecks Arch Surg 2021. [PMID: 34036407 DOI: 10.1007/s00423-021-02203-y] [Reference Citation Analysis]
34 Berlth F, Plum PS, Chon S, Gutschow CA, Bollschweiler E, Hölscher AH. Total minimally invasive esophagectomy for esophageal adenocarcinoma reduces postoperative pain and pneumonia compared to hybrid esophagectomy. Surg Endosc 2018;32:4957-65. [DOI: 10.1007/s00464-018-6257-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]